|
ACT |
artemisinin-based combination therapy |
|
AL |
artemether/lumefantrine (coartemether) |
|
AQ |
amodiaquine |
|
AS |
artesunate |
|
BCG |
bacillus Calmette-Guérin |
|
BEmONC |
basic emergency obstetric and newborn care |
|
BP |
blood pressure |
|
C° |
degree Celsius |
|
CEmONC |
comprehensive emergency obstetric and newborn care |
| D1 (D2, D3, etc.) | Day 1 or first day (Day 2 or 2nd day, Day 3 or 3rd day, etc.) |
|
dl |
decilitre |
|
g |
gram |
|
HBV |
hepatitis B virus |
|
HIV |
human immunodeficiency virus |
|
IM |
intramuscular administration |
|
IU |
international unit |
|
IV |
intravenous administration |
|
kg |
kilogram |
|
LMP |
last menstrual period |
|
M |
million |
|
mg |
milligram |
|
ml |
millilitre |
|
mmHg |
millimetre of mercury |
|
mmol |
millimole |
| MSF | Médecins Sans Frontières |
|
MQ |
mefloquine |
| MUAC | mid-upper arm circumference |
|
MVA |
manual vacuum aspiration |
|
PMTCT |
prevention of mother-to-child transmission |
|
PO |
per os – oral administration |
| PROM | premature rupture of membranes |
|
SC |
subcutaneous administration |
|
SP |
sulfadoxine/pyrimethamine |
| SpO2 | saturation of arterial blood with oxygen measured by pulse oximetry |
|
tab |
tablet |
|
TB |
tuberculosis |
|
TV |
tetanus vaccine |
|
UNICEF |
United Nations Children's Fund |
|
WHO |
World Health Organization |